Sanofi : Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed Nov 2, 2017 02:31AM
Alnylam and Sanofi Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy Sep 20, 2017 07:00AM
Alnylam and Sanofi Genzyme Report Positive Results from Ongoing Phase 2 Open-Label Extension Study with Investigational RNAi Therapeutic Fitusiran in Patients with Hemophilia A and B With or Without I Jul 10, 2017 09:30AM
Sanofi Delivers Robust Q1 2017 Financial Results Apr 28, 2017 01:33AM
Sanofi (SNY) Says New Data to be Presented at AAN Suggest Positive Effects of Aubagio on Cortical Gray Matter Atrophy Apr 25, 2017 08:36AM
View Older Stories

Apr 25, 2017 08:30AM New Data Suggest Positive Effects of Sanofi Genzyme’s Aubagio® (teriflunomide) on Cortical Gray Matter Atrophy
Apr 25, 2017 08:08AM Sanofi Genzyme's (SNY) New Investigational Data on Lemtrada Six-Year Efficacy in MS to be Presented at AAN
Apr 25, 2017 08:00AM New Investigational Data on Six-Year Efficacy of Sanofi Genzyme’s Lemtrada® (alemtuzumab) in Multiple Sclerosis Patients Who Experienced Relapse Between Treatment Courses To Be Presented at AAN
Mar 22, 2017 07:30AM Sanofi Genzyme Extends its Multiple Myeloma Journey Partners Program to Cities Nationwide to Help Improve Patient Outcomes through Peer-to-Peer Education
Feb 8, 2017 01:44AM Sanofi Delivers 2016 Sales and Business EPS(1) Growth at CER(2)
Oct 15, 2015 11:00AM Sanofi Pasteur and the Infectious Disease Research Institute Partner on a Global-Health, Open-Innovation, Vaccine Research & Development Center
Aug 3, 2015 08:00AM New Analysis Reports Lower Rates of Serious Cardio-Respiratory Events Among Study Participants Administered Higher-Dose Influenza Vaccine
Jul 14, 2015 08:00AM Sanofi Pasteur Ships First 2015-2016 Seasonal Influenza Vaccine Doses in United States
Jul 10, 2015 09:28AM Merial Introduces Oravet® Dental Hygiene Chews for Dogs
Mar 25, 2015 12:15PM Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age
Mar 18, 2015 08:45AM Nasacort® Allergy 24HR Partners with The Book of Awesome Author and Renowned Smell Expert to Celebrate the Happy Smells of Spring
May 16, 2011 02:05PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine
Mar 29, 2011 05:21PM BlackRock (BLK) Replacing Genzyme (GENZ) in S&P 500
Mar 23, 2011 10:37AM Canaccord Genuity Morning Coffee on Merck & Co. (MRK) and Sanofi-Aventis (SNY): So Long, Farewell, Au Revoir
Mar 7, 2011 08:11AM Genzyme (GENZ) Board Unanimously Recommends Shareholders Approves Sanofi-Aventis (SNY)
Feb 18, 2011 05:32PM Top 10 News Items 2/14-2/18: NYSE Euronext/Deutsche Boerse Announces Definitive Agreement, Sanofi, Genzyme Finally Approve Deal, Stocks Continue Higher, Up 28% Since Sept.
Feb 18, 2011 10:00AM Jefferies Cuts Estimate & Raises Price Target on BioMarin Pharmaceutical (BMRN), Maintains Buy Rating
Feb 17, 2011 10:34AM Canaccord Genuity Morning Coffee on Sanofi-Aventis (SNY) and Genzyme (GENZ): An Extra $5 Will Help The Medicine Go Down
Feb 17, 2011 08:22AM Jefferies Downgrades Genzyme (GENZ) to Hold, Lowers EPS Estimates For FY11 & FY12
Feb 17, 2011 08:22AM Morgan Joseph Downgrades Genzyme (GENZ) to Hold; To be Acquired for $74 Plus CVRs
Feb 16, 2011 12:13PM Notable ETF Movers of the Day 02/16: (XRT) (USO) (TAN) Higher; (UNG) (VXX) (UUP) Lower
Feb 16, 2011 10:29AM Notable Mergers and Acquisitions of the Day 02/16: GENZ/SNY, BEE, ARG/APD
Feb 16, 2011 09:09AM Pre-Open Movers 2/16: (FDO) (VCLK) (DELL) Higher; (TNGN) (DSCO) (OMX) Lower
Feb 16, 2011 06:44AM Genzyme (GENZ) Agrees To Be Acquired by Sanofi-aventis (SNY) for $20.1 Billion
Feb 15, 2011 12:46PM Genzyme (GENZ) Reportedly Acquired by Sanofi-Aventis for $19.2B
Feb 15, 2011 12:01PM Genzyme (GENZ) Jumps On Reports Deal Reached at $74/Share Plus Rights
Feb 15, 2011 11:57AM Genzyme Corp. (GENZ) sees upside on news Sanofi-Aventis (SNY) deal could be announced soon
Feb 10, 2011 05:49PM Goldman Sachs (GS) Has 6.8% Stake in Genzyme (GENZ, SNY)
Feb 1, 2011 02:15PM Genzyme (GENZ) Stock Volatile With Pushing and Pulling In Sanofi Deal
Feb 1, 2011 12:10PM Genzyme (GENZ) Valued at $20B by Sanofi Aventis; Deal Could Happen Within a Week
Feb 1, 2011 11:57AM Genzyme (GENZ) Dips On Sanofi Headlines
Feb 1, 2011 11:53AM Sanofi (SNY) talks said to value Genzyme (GENZ) at $76-$77/share with CVR fee -Bloomberg
Jan 31, 2011 08:37AM Genzyme (GENZ) Will Allow Sanofi-Aventis To Conduct Due Diligence
Jan 24, 2011 12:21PM This Hedge Fund Guru Profited Big-Time From the Buyout of Genoptix (GXDX), See What Other Targets He Is Buying
Jan 24, 2011 07:58AM Sanofi-aventis (SNY) Tenders 0.4% of Genzyme (GENZ); Extends Deadline
Jan 12, 2011 01:46PM Barclays Maintains an 'Equalweight' on Genzyme (GENZ); Slightly Weaker Results, Focus Remains on Sanofi Process
Jan 12, 2011 11:53AM Genzyme (GENZ) Shares Rise as Sanofi's (SNY) Proposed Bid Wins EU Antitrust Approval
Jan 10, 2011 08:17AM Genzyme (GENZ) Says Talks with Sanofi-Aventis (SNY) Continuing
Dec 21, 2010 11:58AM Genzyme (GENZ) Reportedly Open to Price In Sanofi (SNY) Takeover Battle
Dec 20, 2010 08:37AM Takeover Target Genzyme (GENZ) Has Meeting at 1PM ET
Dec 13, 2010 10:20AM Genzyme (GENZ) Board Reiterates Position Following sanofi (SNY) $69/Share Tender Results
Nov 30, 2010 08:38AM Ticonderoga Maintains a 'Neutral' on Evercore Partners (EVR); Dynegy Breakdown Highlights "Key Deal" Risk for EVR
Nov 26, 2010 09:13AM Genzyme (GENZ) Chief Termeer Affirms $69/Share Bid Offers No Starting Point for Discussions (SNY)
Nov 9, 2010 11:16AM Canaccord Genuity Maintains a 'Buy' on Amicus Therapeutics (FOLD); Rolling Out New Amigal Trials With GSK's Support
Nov 8, 2010 01:30PM Sanofi-aventis (SNY) Seeks Clarification from Genzyme (GENZ) Over Potential Board Actions
Oct 28, 2010 12:12PM sanofi-aventis (SNY) Expands Presence in China with $520.6M Acquisition of BMP Sunstone (BJGP)
Oct 22, 2010 11:37AM Genzyme (GENZ) Confirms Issues Discussed in Presentation This Morning: $89/Share Estimate, Q4, FY11 Outlook
Oct 22, 2010 10:53AM Genzyme (GENZ) Thinks its Worth $89/Share Based on Strong FY11 EPS View
Oct 13, 2010 04:17PM Genzyme Corp. (GENZ) To Hold First Analyst and Investor Meeting October 22
Oct 8, 2010 10:31AM Notable Mergers and Acquisitions of the Day 10/08: ALEX, GENZ/SNY
View Older Stories